STING1 and urinary bladder carcinoma: As illustrated in Figure 6c, Choi et al. engineered urea-driven nanomotors (STING@nanomotor) composed of chitosan-heparin electrostatic complexes encapsulating a STING agonist, designed to enhance immunotherapy for bladder cancer [122].